Exemestane is better than tamoxifen in years 2-5 after breast cancer

Benzer Materyaller

• Breast cancer patients can stop tamoxifen after 5 years
  Yazar:: Gottlieb, Scott
  Baskı/Yayın Bilgisi: (2001)
• Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen
  Yazar:: Bertelli, G., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
  Yazar:: van Nes, J. G. H., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids
  Yazar:: Francini, G, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Patients with breast cancer can stop tamoxifen after five years
  Yazar:: Gottlieb, Scott
  Baskı/Yayın Bilgisi: (2001)